Intranasal fractionated administration of desamino-D-arginine vasopressin (DDAVP) in patients with von Willebrand's disease

B Garicochea et al. Ann Hematol. 1991 Feb-Mar.

. 1991 Feb-Mar;62(2-3):81-2.

doi: 10.1007/BF01714906.

No abstract available

Similar articles

Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S, Harris AS, Nilsson IM. Lethagen S, et al. Blut. 1990 Mar;60(3):187-91. doi: 10.1007/BF01720274. Blut. 1990. PMID: 2107887
Effectiveness of D-arginine vasopressin in von Willebrand's disease.
Bala L, Boggio L, Green D. Bala L, et al. Curr Hematol Rep. 2005 Jan;4(1):1-2. Curr Hematol Rep. 2005. PMID: 15610653 No abstract available.
Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
Takahashi H. Takahashi H. Thromb Res. 1981 Feb 15-Mar 1;21(4-5):357-65. doi: 10.1016/0049-3848(81)90136-5. Thromb Res. 1981. PMID: 6791293 No abstract available.
Diagnosis and management of von Willebrand's syndrome.
Rick ME. Rick ME. Med Clin North Am. 1994 May;78(3):609-23. doi: 10.1016/s0025-7125(16)30149-3. Med Clin North Am. 1994. PMID: 8170261 Review.
[Variant forms of von Willebrand's disease].
Papaian LP, Golovina OG. Papaian LP, et al. Ter Arkh. 1990;62(7):86-92. Ter Arkh. 1990. PMID: 2251672 Review. Russian.